Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TARS2P1 is a human pseudogene closely related to the protein-coding gene threonyl-tRNA synthetase 2, mitochondrial (TARS2)[5]. Unlike TARS2, which serves as a mitochondrial class-II aminoacyl-tRNA synthetase and is involved in mitochondrial protein translation and human disease[1][3], TARS2P1 does not encode a functional protein and is generally of interest only for genomic research rather than drug discovery or biomarker development. Pseudogenes like TARS2P1 may contribute to genome structure or regulation but are not considered therapeutic targets due to lack of protein expression or biological function[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Threonyl-tRNA synthetase 2, mitochondrial pseudogene 1 (TARS2P1).